Edition:
India

Acer Therapeutics Reorganizes; Headcount Reduced To 19 Employees


Friday, 5 Jul 2019 

July 5 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS INC - HEADCOUNT HAS BEEN REDUCED FROM 48 TO 19 EMPLOYEES.ACER THERAPEUTICS INC - RESTRUCTURING EXPECTED TO EXTEND CASH RUNWAY THROUGH END OF 2020.ACER THERAPEUTICS INC - ACER PLANS TO DISCUSS EDSIVO CRL WITH FDA AND WILL CONTINUE TO ADVANCE ADDITIONAL PIPELINE PRODUCTS.ACER THERAPEUTICS INC - EXPECTS TO INITIATE A PIVOTAL BRIDGING STUDY IN Q4 2019 OF ACER-001 FOR UREA CYCLE DISORDERS (UCDS).ACER THERAPEUTICS - EXPECTS TO DISCLOSE SPECIFIC INDICATIONS FOR DEVELOPMENT OF OSANETANT IN LATE JULY 2019.ACER THERAPEUTICS INC - PRE-COMMERCIAL ACTIVITIES OF EDSIVO (CELIPROLOL) HAVE BEEN HALTED..ACER THERAPEUTICS INC - TO INITIATE A CLINICAL STUDY BY MID-2020 TO EVALUATE PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY OF OSANETANT .